TLSI
NASDAQ · Biotechnology
Trisalus Life Sciences Inc
$4.43
-0.03 (-0.67%)
Open$4.42
Previous Close$4.46
Day High$4.45
Day Low$4.33
52W High$7.95
52W Low$2.20
Volume—
Avg Volume911.2K
Market Cap154.77M
P/E Ratio—
EPS$-1.07
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
-2.3% upside
Current
$4.43
$4.43
Target
$4.33
$4.33
$2.61
$4.33 avg
$5.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 41.62M | 47.23M | 45.65M |
| Net Income | -36,162,998 | -3,256,844 | -3,940,718 |
| Profit Margin | -86.9% | -6.9% | -8.6% |
| EBITDA | -30,978,389 | -4,196,050 | -4,663,249 |
| Free Cash Flow | — | -5,024,799 | -4,621,021 |
| Rev Growth | — | +7.1% | +0.6% |
| Debt/Equity | 0.20 | 1.07 | 0.92 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |